Biocon share news, announcements and annual reports
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Biocon Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2004
Last close ₹351.80down ₹0.10 (0.03%)BSE ₹352.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹351.90.
30 Oct: open ₹352.70, high ₹355.50, low ₹348.70
52-week range of traded prices to 30 Oct 2026
₹318.40Low, 23 Oct 2026₹447.15High, 16 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,333 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 115.75
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 64.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.68
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 20,63,63747.1% delivered
Biocon orders, deals and press releases
415 filed, newest first. Page 8 of 9.
Apr 2011
Jan 2011
Oct 2010
Sep 2010
Aug 2010
Jul 2010
May 2010
Apr 2010
29 Apr · Business
Press release dated April 29, 2010, titled "Clinigene Announces Appointment of its New COO". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Apr · Business
Press release dated April 29, 2010, titled "Biocon revenues cross half-billion dollar mark, Revenues at Rs.2,405 crores; EBITDA at Rs. 509 crores; PAT at Rs. 293 crores; Board recommends dividend of Rs. 3.50 per Equity Shares (70%)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Apr · Business
Press release dated April 05, 2010, titled "Biocon Biopharmaceuticals Private Limited becomes wholly owned subsidiary". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2010
22 Mar · Business
Press release dated March 22, 2010, titled "Syngene to Collaborate with Endo Pharmaceuticals to Develop Anti-cancer Novel Therapeutic Molecules". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2010
4 Feb · Business
Press release dated February 04, 2010, titled " Biocon and Bayer join hands to create awareness for self monitoring in diabetics". A copy of the press release shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
22 Jan · Business
Press release dated January 22, 2010 titled "Biocon Explores Investment in Malaysia in partnership with Biotechcorp". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Business
Press release dated January 21, 2010 titled "Biocon Limited Announces Results for the Nine Months Ended December 31, 2009; Revenues at Rs 1,739 crores; EBITDA at Rs 369 crores; PAT at Rs 213 crores". Further a copy of the press release along with Fact Sheet shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
10 Dec · Business
Press release dated December 10, 2009, titled "Biocon and HCG Group of Hospitals Ltd join hands to fight against Cervical Cancer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
22 Oct · Business
Press release dated October 22, 2009 titled "Biocon Limited Announces Results for the Half-Year Ended September 30, 2009; Revenues rise to Rs 1,098 crores; EBITDA at Rs.236 crores; PAT at Rs 132 crores". Further a copy of the press release along with Fact Sheet shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
30 Sep · Business
Company has entered into a definitive agreement, to acquire the bulk pharmaceutical business undertaking of IDL Specialty Chemicals Limited located near Hyderabad, subject to the closing conditions detailed in the said agreement.29 Sep · Business
Press release dated September 29, 2009, titled "Kiran Mazumdar Shaw in Financial Times' 'Top 50 women in business' list". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Sep · Business
Vide its letter dated September 24, 2009 regarding a press release dated September 23, 2009, titled "Biocon among 20 Indian companies in Forbes 'Best Under A Billion' list". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Sep · Business
Press release dated September 11, 2009, titled "Biocon Limited and Amylin Pharmaceuticals Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
20 Aug · Business
Press release dated August 20, 2009, titled "Kiran Mazumdar Shaw features on the Forbes list of The World's 100 Most Powerful Women". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Aug · Business
Vide its letter dated August 11, 2009, regarding a press release dated August 10, 2009 titled "The Syngene Vivarium receives official accreditation by AAALAC". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
23 Jul · Business
Press release dated July 23, 2009 titled "Biocon's Q1 FY ' 10 Results Surge Ahead Revenues Rs.505 crores. EBITDA Rs.111crores. PAT Rs.58 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
29 Jun · Business
Press release dated June 29, 2009, titled "Biocon Announces Strategic Collaboration with Mylan to enter the Global Generic Biologics Market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jun · Business
Press release dated June 08, 2009, titled "Biocon inks partnership with ISB to launch the Biocon Cell for Innovation Management ; Initial contribution of Rs. 1 crore to set up the cell". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
29 May · Business
Press release dated May 29, 2009, titled "Biocon launches BASALOG(TM) - long lasting basal insulin for Type 1 & Type 2 Diabetics". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 May · Business
Press release dated May 11, 2009 titled "Kiran Mazumdar Shaw awarded the prestigious 'Nikkei Asia Prize' 2009 for Regional Growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
28 Apr · Business
Press release dated April 28, 2009 titled "Biocon Group Delivers 16% Growth in Operating Profits - PAT Impacted By MTM. Board Recommends Rs.3 per share (60%) As Dividend ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
23 Mar · Business
Press release, dated March 23, 2009, titled "Bristol-Myers Squibb and Biocon's Syngene open new R&D Facility at Biocon Park". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Mar · Business
Press release, dated March 18, 2009, titled "Biocon wins prestigious 2009 BioSingapore Asia Pacific Biotechnology Award for Best Listed Company". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Mar · Business
Press release issued by Syngene International Limited ("Syngene") a subsidiary of the Company, dated March 09, 2009, titled "Syngene and DuPont Crop Protection Forge Alliance Partnership". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Business
Press release issued by Axicorp GmbH ("Axicorp"), a Biocon Company, which has been released at Friedrichsdorf, Germany, dated March 02, 2009, titled "Axicorp Press Release". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
21 Jan · Business
Press release issued by Syngene International Limited ("Syngene") a wholly owned subsidiary of the Company, dated January 21, 2009, titled "Syngene partners with Sapient Discovery to expand integrated drug discovery offerings". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Business
Press release dated January 21, 2009 titled "Biocon's 9 months FY-09 maintains growth momentum, Revenues : Rs. 1,187 crs (including AxiCorp) : Rs. 889 crs (excluding AxiCorp) : EBITDA Rs. 277 crs : PAT Rs. 174 crs (excluding MTM)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
10 Oct · Business
Press release dated October 09, 2008 titled "NeoBiocon and Abraxis Bioscience Launch Abraxane in the UAE For Treatment of Breast Cancer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
22 Sep · Business
Press release dated September 22, 2008 titled " Biocon is the 7th largest biotech employer in the world: Med Ad News ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Sep · Business
Press release dated September 08, 2008, titled "Biocon Limited presents human clinical data on IN-105 (oral insulin) at the EASD meeting in Rome". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
18 Jul · Business
Press release dated July 18, 2008, titled "Biocon and Abraxis Bioscience Launch Abraxane in India For Treatment of Breast Cancer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jul · Business
Press release dated July 17, 2008, titled "Biocon is world's top 20 biotechnology company : Med Ad News". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
4 Jun · Business
Press release dated June 04, 2008, titled "Biocon launches 'ERYPRO Safe(TM)'and 'NUFIL Safe (TM)' Pre-filled Syringes in collaboration with Safety Syringes Inc., USA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
11 Feb · Business
Press release dated February 11, 2008, titled "Biocon acquires 70% stake in German Pharmaceutical company, AxiCorp : Biosimilars will be main focus.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
17 Jan · Business
Press release dated January 17, 2008, titled "Biocon and IATRICa Partner to develop Novel Immunoconjugate Therapeutics against Cancer and Infectious Diseases.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jan · Business
Press release dated January 17, 2008, titled "Biocon's 9 Months FY 08 Registers Growth in Revenues & Profits Post Enzymes Divestment; Revenues Rs. 811 crs: EBITDA Rs. 240 crs: PAT Rs. 160 crs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
18 Oct · Business
Press release dated October 18, 2007, titled "Biocon Limited and Abraxis Bioscience announce the Approval of "Abraxine" in India for the treatment of Breast Cancer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Oct · Business
Press release dated October 18 2007, titled "Biocon's H-1 FY'08 Delivers 27% Profit Growth". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.